Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Michael Serbin"'
Autor:
Caroline M. Tanner, Stanley N. Caroff, Andrew J. Cutler, William R. Lenderking, Huda Shalhoub, Véronique Pagé, Ericha G. Franey, Michael Serbin, Chuck Yonan
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract Background Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with antipsychotic use. Data from RE-KINECT, a real-world study of antipsychotic-treated outpatients, were analyzed to assess the effec
Externí odkaz:
https://doaj.org/article/7624d1f68f3346d79bebd79e645eff49
Autor:
Peter LeWitt, Olga Klepitskaya, Michael Serbin, Eric Jen, Stacey Rattana, Jeffrey Trotter, Grace Liang
Publikováno v:
Tuesday, April 25.
Publikováno v:
Journal of Medical Economics. 24:563-569
To assess from a US payer perspective the relative cost-effectiveness of the catechol-A Markov model was created to estimate cost-effectiveness of adjunctive opicapone treatment compared with adjunctive entacapone treatment in a synthetic cohort of 1
Autor:
Andrew LaPrise, Michael Serbin, Vanessa Shih, Szilard Kiss, Joanna Campbell, Arghavan Almony, Charles C. Wykoff
Publikováno v:
Ophthalmology. 127:1179-1188
Purpose To assess anti-vascular endothelial growth factor (VEGF) management patterns and anatomic and visual acuity (VA) outcomes among patients with neovascular age-related macular degeneration (nAMD) in United States clinical practice. Design Retro
Publikováno v:
Journal of Comparative Effectiveness Research. 8:1077-1088
Aim: Utilize the Bucher indirect treatment comparison (ITC) method to compare valbenazine and deutetrabenazine efficacy using clinical trial data. Methods: Outcomes included mean change from baseline in Abnormal Involuntary Movement Scale (AIMS) tota
Publikováno v:
Journal of Medical Economics. 24:891-892
Dear Editor,We appreciate the interest from Xue et al. in our cost-effectiveness analysis of valbenazine versus deutetrabenazine for the treatment of tardive dyskinesia (TD)1, and are gratified tha...
Autor:
Szilárd, Kiss, Joanna, Campbell, Arghavan, Almony, Vanessa, Shih, Michael, Serbin, Andrew, LaPrise, Charles C, Wykoff
Publikováno v:
Ophthalmology. 127(9)
To assess anti-vascular endothelial growth factor (VEGF) management patterns and anatomic and visual acuity (VA) outcomes among patients with neovascular age-related macular degeneration (nAMD) in United States clinical practice.Retrospective observa
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 22:939-947
Uncertainty regarding clopidogrel effectiveness attenuation because of a drug-drug interaction with proton pump inhibitors (PPI) has led to conflicting guidelines on concomitant therapy. In particular, the effect of this interaction in patients who u
Autor:
F. Rocha, Olga Klepitskaya, K. Olson, Grace S. Liang, Khodayar Farahmand, Joaquim J. Ferreira, Patrício Soares-da-Silva, Stuart Isaacson, Michael Serbin, Mark F. Lew, Robert A. Hauser
Publikováno v:
Parkinsonism & Related Disorders. 79:e58
Publikováno v:
Value in Health. 19:A54